SAN FRANCISCO—Renal transplant recipients and non-transplant patients with end-stage renal disease (ESRD) who develop bladder cancer have more extensive disease distribution at diagnosis than bladder cancer patients in the general population, according to researchers. The disease distribution between the transplant and ESRD patients is similar, however.